On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NetworkNewsAudio » Page 19

NetworkNewsAudio

WednesdaySep 20, 2017 11:36 am

NetworkNewsAudio – Greenkraft, Inc. (GKIT) Interview

About Greenkraft, Inc. Greenkraft, Inc. (GKIT) is a nationally recognized company specializing in the production of alternative fuel automotive products, including engines and commercial trucks. Located in Santa Ana, California, the company’s mission is to provide clean, green, energy efficient automotive products that have a price advantage coupled with unparalleled American performance. Established in 2008, Greenkraft, Inc. serves the commercial truck market powered by the alternative fuels CNG and LPG in classes 4, 5, 6 and 7. View Complete Profile

Continue Reading

MondaySep 18, 2017 11:52 am

NetworkNewsAudio – Medical Innovation Holdings, Inc. (MIHI) Interview

About Medical Innovation Holdings, Inc. Medical Innovation Holdings, Inc., a Colorado-based publicly traded company, owns and operates strategically aligned healthcare service and product companies focused on the delivery of patient care, management services for physician offices, lab services, and pharma; and non-pharma medicines and alternatives to patients and consumers. Healthcare services are delivered and managed through the company’s MSO, 3Point Care. 3Point Care uses virtual telemedicine with a unique customized software and hardware platform as a way of bringing quality medical care to rural and medically underserved areas (MUAs) of the country. View Complete Profile

Continue Reading

ThursdayJul 20, 2017 11:45 am

NetworkNewsAudio – Lexaria Bioscience Corp. (OTCQB: LXRP) Interview

About Lexaria Bioscience Corp. Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products. View Complete Profile

Continue Reading

FridayJul 07, 2017 1:31 pm

NetworkNewsAudio – Patriot One Technologies, Inc. (OTCQB: PTOTF) Interview

About Medical Transcription Billing, Corp. Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology. Developed through a NATO-funded project at McMaster University, Patriot One’s disruptive NForce CMR1000 (PATSCAN) technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide. View Complete Profile

Continue Reading

WednesdayJun 07, 2017 8:59 am

NetworkNewsAudio – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Interview

About BriaCell Therapeutics Corp. BriaCell is an immuno-oncology-focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell is currently conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a combination study with pembrolizumab [Keytruda; manufactured by Merck & Co., Inc.] or ipilimumab [Yervoy; manufactured by Bristol-Myers Squibb Company]. The combination study is listed in ClinicalTrials.gov as NCT03328026. BriaCell is developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing. Bria-OTS, which is expected to cover over 90 percent…

Continue Reading

Contact us: 212.418.1217

NetworkNewsWire

1324 Lexington Ave., Suite 117
New York, NY 10128
(212) 418-1217

Copyright . NetworkNewsWire® / 1324 Lexington Ave., Suite 117 New York, NY 10128 (212) 418-1217 / Disclaimers